Dr.Anti-Cancer
Roberto García

Low-dose tomography (LDCT) scan for smokers: when it detects lung cancer early and saves lives

Low-dose tomography (LDCT) scan for smokers: when it detects lung cancer early and saves lives

Lung cancer is one of the most common causes of cancer death in the world, and in many cases it is diagnosed when the disease is already advanced. LDCT low-dose tomography for smokers or ex-smokers: when it can help detect lung cancer in time is a key question, because this study can change the panorama: it allows the identification of abnormalities in the lung when there are still no symptoms, at a time when the possibilities of treatment are usually much greater.

What is low-dose CT and how does it work?

LDCT is an imaging study that takes detailed pictures of the inside of the chest with low-intensity x-rays. Unlike other tests, it usually doesn’t need intravenous contrast or complicated preparation. The equipment rotates around the body in a matter of seconds and produces cross-sectional images of the lungs with very good resolution.

Differences between LDCT and a conventional CT scan

Differences between LDCT and a conventional CT scan

The main difference is in the radiation dose. A conventional chest CT scan can emit five to ten times more radiation than an LDCT. Both generate similar images, but the low-dose version reduces diagnostic quality very little in exchange for much lower exposure. Therefore, it is suitable as a repeated screening study in people at high risk.

Why LDCT Reduces Radiation Exposure

LDCT protocols adjust equipment parameters—such as tube voltage and current—to emit as little radiation as possible without losing the ability to detect small lung nodules. According to data from the NLST (National Lung Screening Trial) study, published in the New England Journal of Medicine, this approach can detect tumors in early stages and significantly reduce the risk of cumulative exposure. This approach allows tumors to be detected in early stages and significantly reduces the risk of cumulative exposure.

Who should consider lung cancer screening with LDCT?

Not everyone who has smoked needs this test. The criteria are clearly defined and seek to concentrate the benefit on those who are most likely to develop the disease.

Recommended age and smoking history criteria

Leading health organizations recommend annual screening with LDCT for people between the ages of 50 and 80 who have smoked at least 20 pack-years — equivalent to a pack a day for 20 years — and who currently smoke or have quit smoking in the past 15 years. These thresholds are based on evidence from the NLST and the European NELSON study, which showed a significant reduction in lung cancer mortality in this population.

Other risk factors to consider beyond smoking

Although smoking is the main risk factor, there are other conditions that may require a case-by-case evaluation: long-term exposure to radon, a family history of lung cancer, work contact with asbestos or arsenic, and chronic lung diseases such as chronic obstructive pulmonary disease (COPD). In these cases, the decision to screen should be made with medical criteria and not as a routine.

Benefits of Early Screening: How Early Detection Saves Lives

Reduced lung cancer mortality according to studies

The NELSON study, published in the New England Journal of Medicine in 2020, found that LDCT screening reduced lung cancer mortality by 24% in men and up to 33% in women during follow-up. These results support the use of the study in a high-risk population.

More effective treatment when detected in early stages

When lung cancer is detected in stage I or II, five-year survival rates exceed 60–70%, compared with less than 10% when diagnosed in stage IV. Early detection opens the door to less invasive surgeries, stereotactic radiotherapy and systemic treatments with a better prognosis.

Risks and limitations of low-dose tomography

Like any medical study, the LDCT also has limitations that should be clear when deciding.

False Positives: What It Means to Find Benign Lung Nodules

Most nodules seen on screening are benign. Still, finding them can cause concern and lead to further study. According to the NLST, about 96% of the nodules detected were found to be noncancerous. This does not mean that the study “fails”; It means that the finding of a nodule is the start of an evaluation, not a diagnosis of cancer.

Overdiagnosis and unnecessary additional procedures

Overdiagnosis and unnecessary additional procedures

Overdiagnosis occurs when a tumor is detected that, if it had not been found, would never have caused symptoms or death. In lung cancer screening, it is a recognized phenomenon, although it is difficult to measure it accurately. Individualized evaluation by an oncology specialist helps to make decisions according to the real risk of each patient.

Accumulated radiation exposure from repeated screenings

Although each LDCT emits a low dose of radiation, as it is done annually there is a cumulative exposure over time. This exposure is much lower than that of a conventional CT scan, but it is still a point that the doctor must assess according to the medical history and age of each person. the medical history and age of each person.

How often should screening be done and when should it be stopped?

Recommended intervals between LDCT studies

For those who meet the criteria, a study once a year is recommended. This interval allows changes to be identified in nodules already seen and new lesions to be detected with sufficient time to act.

When to stop screening based on age and health status

Screening is usually stopped at age 80, when the person has been smoking for more than 15 years, or when their health condition makes treating a detected cancer not viable or not considered appropriate. The decision, in any case, must be individualized.

What to Expect on the Day of the Low-Dose CT Study

How to Prepare for LDCT (Fasting, Medicines, and Clothing)

LDCT does not require fasting. In most cases, it is not necessary to stop taking medicines. It is recommended to wear comfortable clothes and without zippers or metal accessories, because they can interfere with the images. The doctor will indicate if there are any additional recommendations according to each case.

Duration of the procedure and level of discomfort

The study usually takes less than ten minutes. The person lies on a table that moves slowly around the equipment, while holding their breath for a few seconds. It is not painful or invasive, and most experience it as a totally tolerable procedure.

Interpreting Results: Lung Nodules and Next Steps

What to do if nodules are found on the LDCT

Not all nodules need to be acted on immediately. Size, shape, density, and growth speed matter. To order the evaluation, the Lung-RADS system is used, which classifies the findings according to the level of suspicion and provides guidance on the next step: control at six months, one year or additional studies.

When Biopsy, PET-CT, or Additional Follow-Up Is Needed

When Biopsy, PET-CT, or Additional Follow-Up Is Needed

If a nodule has suspicious features—larger size, irregular borders, or documented growth—positron emission tomography (PET-CT) may be ordered to assess the metabolic activity of the lesion, or a biopsy may be ordered to confirm the tissue diagnosis. PET-CT combines functional and anatomical information, making it a valuable tool for staging lung cancer. PET-CT combines functional and anatomical information, making it a valuable tool for staging lung cancer.

Red Flags That Require Immediate Medical Attention

Respiratory symptoms that should not be ignored between screenings

Annual screening is not a substitute for medical consultation if symptoms appear. Persistent cough for more than three weeks, blood in the sputum, chest pain, shortness of breath without a clear cause, unexplained weight loss, or hoarseness that does not improve should be evaluated as soon as possible, without waiting for the next LDCT.

Frequently Asked Questions About Low-Dose Tomography in Smokers and Ex-Smokers

¿La LDCT es dolorosa o invasiva?

No. It is a non-invasive study and, in general, without relevant discomfort. It does not require needles, contrast or sedation.

¿Cuánto cuesta el cribado de cáncer de pulmón y lo cubre el seguro?

Costs may vary. In Panama, it is best to consult with the specialist about the available options and guidance on insurance coverage according to each medical plan.

¿Puedo hacerme la LDCT si dejé de fumar hace años?

Yes. If you quit smoking within the last 15 years and meet the criteria for age and smoking history, you are still a candidate for screening. Quitting smoking doesn’t immediately erase the cumulative risk.

¿Qué pasa si nunca fumé pero estuve expuesto al humo de segunda mano?

Long-term exposure to secondhand smoke is a recognized risk factor for lung cancer. However, current LDCT screening criteria do not formally include this group. If there is concern, it is advisable to consult with an oncology specialist for an individualized risk assessment.

If you have a history of smoking or risk factors and want to know if you are a candidate for lung cancer screening, Dr. Roberto García —a specialist in oncology and oncological surgery— can guide you with medical criteria, without unnecessary studies and with close accompaniment at each stage of the process. You can contact him at The Panama Clinic, in Panama City, at 6545-6968.

Content reviewed by Dr. Roberto García, specialist in Oncology and Oncological Surgery.

If you are evaluating LDCT low-dose tomography for smokers or former smokers: when it can help detect lung cancer early, it is ideal to do it with medical guidance and according to your risk factors.

Related Blogs

Contact us

Practical Guide for Caregivers and Cancer Patients
Order this Book Here